Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 14, 2012; 18(22): 2784-2792
Published online Jun 14, 2012. doi: 10.3748/wjg.v18.i22.2784
Published online Jun 14, 2012. doi: 10.3748/wjg.v18.i22.2784
Table 1 Characteristics of the study population
Features | mean ± SD | Minimum | Maximum |
Gender (male/female) | 91/23 | ||
HBV DNA (copies/mL) | |||
(< 1000/≥ 1000) | 44/70 | ||
(< 103/103-105/≥ 105) | 44/32/38 | ||
E antigen (+/-) | 52/62 | ||
Age (yr) | 38.32 ± 11.36 | 15 | 67 |
PLT( × 109/L) | 174.44 ± 62.68 | 50.6 | 334 |
T.Bil (g/dL) | 0.88 ± 0.49 | 0.27 | 3.14 |
D.Bil (g/dL) | 0.29 ± 0.23 | 0.08 | 1.39 |
ALT (IU/L) | 69.32 ± 116.40 | 10.00 | 983 |
AST (IU/L) | 48.60 ± 64.56 | 13 | 594 |
ALB (g/dL) | 4.15 ± 0.43 | 2.85 | 5.26 |
GLOB (g/dL) | 2.98 ± 0.52 | 1.75 | 4.47 |
ALP (IU/L) | 80.10 ± 27.38 | 24 | 154 |
GGT (IU/L) | 59.46 ± 66.92 | 5 | 430 |
PT (s) | 12.01 ± 1.58 | 9.3 | 18.1 |
Table 2 Noninvasive simple fibrosis models composed of routine clinical and laboratory parameters
Fibrosis test | Calculation |
FI | 8.0-0.01 × PLT (× 109/L)-ALB (g/dL) |
APRI | AST (IU/L) × 100/PLT (× 109/L) |
FIB-4 | Age (yr) × AST (IU/L)/PLT (× 109/L) × ALT (IU/L) 1/2 |
FCI | ALP (IU/L) × T.bil (g/dL)/ALB (g/dL)/ PLT (× 109/L) |
Age-AST model | Age (yr)/AST (IU/L) |
AP index | Age (yr)/PLT (× 109/L) |
Table 3 Correlation analysis of seven models and different fibrosis stages (F0-F1, F2-F3 and F4)
F0-F1, F2-F3 and F4 fibrosis stages | Bivariate Spearman’s rank correlation coefficient | P value |
FI | 0.231 | 0.06 |
APRI | 0.146 | 0.237 |
FIB-4 | 0.307 | 0.012 |
FCI | 0.159 | 0.20 |
Age-AST model | 0.132 | 0.286 |
AP index | 0.246 | 0.045 |
GP model | 0.441 | 0.000 |
Table 4 Validity of age-platelet count ratio, aspartate aminotransferase-platelet ratio, age-aspartate aminotransferase model, fibrosis index, FIB-4 and fibrosis-cirrhosis index for prediction of minimal fibrosis (F0-F1) and comparison with globulin/platelet model
Fibrosis test | Cutoff value | Specificity % | Sensitivity % | PPV % | NPV % | AUC (95% CI) | Standard error | P value(vs GP model) |
FI | 1.58 | 41.1 | 89.7 | 61.2 | 79.4 | 0.695 (0.600-0.791) | 0.049 | > 0.05 |
APRI | 0.85 | 87.5 | 41.4 | 77.4 | 59.0 | 0.635 (0.533-0.738) | 0.052 | < 0.05 |
FIB-4 | 1.7 | 85.7 | 51.7 | 78.9 | 63.1 | 0.720 (0.627-0.813) | 0.047 | > 0.05 |
FCI | 0.17 | 80.4 | 55.2 | 74.5 | 63.4 | 0.692 (0.594-0.790) | 0.050 | > 0.05 |
Age-AST model | - | 19.6 | 94.8 | 55.0 | 78.4 | 0.524 (0.417-0.632) | 0.055 | < 0.001 |
AP index | 0.17 | 46.4 | 89.7 | 63.4 | 81.3 | 0.726 (0.634-0.818) | 0.047 | > 0.0 |
GP model | 1.68 | 69.6 | 72.4 | 71.2 | 70.8 | 0.762 (0.676-0.848) | 0.044 |
Table 5 Validity of age-platelet count ratio, aspartate aminotransferase-platelet ratio, age-aspartate aminotransferase model, fibrosis index, FIB-4, and fibrosis-cirrhosis index for prediction of cirrhosis (F4) and comparison with globulin/platelet model
Fibrosis test | Cutoff value | Specificity % | Sensitivity % | PPV % | NPV % | AUC (95% CI) | Standard error | P value(vs GP model) |
FI | 2.16 | 53.4 | 81.8 | 15.8 | 96.4 | 0.717 (0.569-0.865) | 0.075 | > 0.05 |
APRI | 0.77 | 72.8 | 72.7 | 22.2 | 96.1 | 0.703 (0.584-0.822) | 0.061 | > 0.05 |
FIB-4 | 2.29 | 89.3 | 72.7 | 42.0 | 96.8 | 0.768 (0.050-0.931) | 0.083 | > 0.05 |
FCI | 0.10 | 68.0 | 81.8 | 21.4 | 97.2 | 0.738 (0.612-0.864) | 0.064 | > 0.05 |
Age-AST model | - | - | - | - | 0.486 (0.365-0.608) | 0.062 | - | |
AP index | 0.32 | 74.8 | 72.7 | 23.6 | 96.2 | 0.735 (0.575-0.895) | 0.082 | > 0.05 |
GP model | 2.53 | 84.5 | 72.7 | 33.4 | 96.7 | 0.781 (0.638-0.924) | 0.073 |
- Citation: Liu XD, Wu JL, Liang J, Zhang T, Sheng QS. Globulin-platelet model predicts minimal fibrosis and cirrhosis in chronic hepatitis B virus infected patients. World J Gastroenterol 2012; 18(22): 2784-2792
- URL: https://www.wjgnet.com/1007-9327/full/v18/i22/2784.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i22.2784